The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Bioidentical Hormones-Global Market Insights and Sales Trends 2024
Synopsis
Bioidentical hormones are hormones that are chemically the same as those that the body produces. Although they are made in a laboratory, bioidentical hormones mimic the hormones the human body produces naturally.
The global Bioidentical Hormones market size is expected to reach US$ 377.8 million by 2029, growing at a CAGR of 2.9% from 2023 to 2029. The market is mainly driven by the significant applications of Bioidentical Hormones in various end use industries. The expanding demands from the Hospitals & Gynecology Clinics, Academic and Research and Others,, are propelling Bioidentical Hormones market. Estrogens, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Progesterone segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Bioidentical Hormones market, driven by demand from China, the second largest economy with some signs of stabilising, the Bioidentical Hormones market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bioidentical Hormones, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bioidentical Hormones market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bioidentical Hormones market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bioidentical Hormones sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bioidentical Hormones covered in this report include SottoPelle, BioTE Medical, Advantage Pharmaceuticals, Full Life Wellness Center, Neuva Aesthetics, Defy Medical and Biostation, etc.
The global Bioidentical Hormones market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
SottoPelle
BioTE Medical
Advantage Pharmaceuticals
Full Life Wellness Center
Neuva Aesthetics
Defy Medical
Biostation
Global Bioidentical Hormones market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bioidentical Hormones market, Segment by Type:
Estrogens
Progesterone
Testosterone
Others
Global Bioidentical Hormones market, by Application
Hospitals & Gynecology Clinics
Academic and Research
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Bioidentical Hormones manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Bioidentical Hormones in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Bioidentical hormones are hormones that are chemically the same as those that the body produces. Although they are made in a laboratory, bioidentical hormones mimic the hormones the human body produces naturally.
The global Bioidentical Hormones market size is expected to reach US$ 377.8 million by 2029, growing at a CAGR of 2.9% from 2023 to 2029. The market is mainly driven by the significant applications of Bioidentical Hormones in various end use industries. The expanding demands from the Hospitals & Gynecology Clinics, Academic and Research and Others,, are propelling Bioidentical Hormones market. Estrogens, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Progesterone segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Bioidentical Hormones market, driven by demand from China, the second largest economy with some signs of stabilising, the Bioidentical Hormones market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Bioidentical Hormones, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Bioidentical Hormones market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Bioidentical Hormones market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Bioidentical Hormones sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Bioidentical Hormones covered in this report include SottoPelle, BioTE Medical, Advantage Pharmaceuticals, Full Life Wellness Center, Neuva Aesthetics, Defy Medical and Biostation, etc.
The global Bioidentical Hormones market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
SottoPelle
BioTE Medical
Advantage Pharmaceuticals
Full Life Wellness Center
Neuva Aesthetics
Defy Medical
Biostation
Global Bioidentical Hormones market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Bioidentical Hormones market, Segment by Type:
Estrogens
Progesterone
Testosterone
Others
Global Bioidentical Hormones market, by Application
Hospitals & Gynecology Clinics
Academic and Research
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Bioidentical Hormones manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Bioidentical Hormones in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Bioidentical Hormones Market Overview
1.1 Bioidentical Hormones Product Overview
1.2 Bioidentical Hormones Market Segment by Type
1.2.1 Estrogens
1.2.2 Progesterone
1.2.3 Testosterone
1.2.4 Others
1.3 Global Bioidentical Hormones Market Size by Type
1.3.1 Global Bioidentical Hormones Market Size Overview by Type (2018-2029)
1.3.2 Global Bioidentical Hormones Historic Market Size Review by Type (2018-2023)
1.3.3 Global Bioidentical Hormones Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Bioidentical Hormones Sales Breakdown by Type (2018-2023)
1.4.2 Europe Bioidentical Hormones Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Bioidentical Hormones Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Bioidentical Hormones Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Bioidentical Hormones Sales Breakdown by Type (2018-2023)
2 Global Bioidentical Hormones Market Competition by Company
2.1 Global Top Players by Bioidentical Hormones Sales (2018-2023)
2.2 Global Top Players by Bioidentical Hormones Revenue (2018-2023)
2.3 Global Top Players by Bioidentical Hormones Price (2018-2023)
2.4 Global Top Manufacturers Bioidentical Hormones Manufacturing Base Distribution, Sales Area, Product Type
2.5 Bioidentical Hormones Market Competitive Situation and Trends
2.5.1 Bioidentical Hormones Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Bioidentical Hormones Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Bioidentical Hormones as of 2022)
2.7 Date of Key Manufacturers Enter into Bioidentical Hormones Market
2.8 Key Manufacturers Bioidentical Hormones Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Bioidentical Hormones Status and Outlook by Region
3.1 Global Bioidentical Hormones Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Bioidentical Hormones Historic Market Size by Region
3.2.1 Global Bioidentical Hormones Sales in Volume by Region (2018-2023)
3.2.2 Global Bioidentical Hormones Sales in Value by Region (2018-2023)
3.2.3 Global Bioidentical Hormones Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Bioidentical Hormones Forecasted Market Size by Region
3.3.1 Global Bioidentical Hormones Sales in Volume by Region (2024-2029)
3.3.2 Global Bioidentical Hormones Sales in Value by Region (2024-2029)
3.3.3 Global Bioidentical Hormones Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Bioidentical Hormones by Application
4.1 Bioidentical Hormones Market Segment by Application
4.1.1 Hospitals & Gynecology Clinics
4.1.2 Academic and Research
4.1.3 Others
4.2 Global Bioidentical Hormones Market Size by Application
4.2.1 Global Bioidentical Hormones Market Size Overview by Application (2018-2029)
4.2.2 Global Bioidentical Hormones Historic Market Size Review by Application (2018-2023)
4.2.3 Global Bioidentical Hormones Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Bioidentical Hormones Sales Breakdown by Application (2018-2023)
4.3.2 Europe Bioidentical Hormones Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Bioidentical Hormones Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Bioidentical Hormones Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Bioidentical Hormones Sales Breakdown by Application (2018-2023)
5 North America Bioidentical Hormones by Country
5.1 North America Bioidentical Hormones Historic Market Size by Country
5.1.1 North America Bioidentical Hormones Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Bioidentical Hormones Sales in Volume by Country (2018-2023)
5.1.3 North America Bioidentical Hormones Sales in Value by Country (2018-2023)
5.2 North America Bioidentical Hormones Forecasted Market Size by Country
5.2.1 North America Bioidentical Hormones Sales in Volume by Country (2024-2029)
5.2.2 North America Bioidentical Hormones Sales in Value by Country (2024-2029)
6 Europe Bioidentical Hormones by Country
6.1 Europe Bioidentical Hormones Historic Market Size by Country
6.1.1 Europe Bioidentical Hormones Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Bioidentical Hormones Sales in Volume by Country (2018-2023)
6.1.3 Europe Bioidentical Hormones Sales in Value by Country (2018-2023)
6.2 Europe Bioidentical Hormones Forecasted Market Size by Country
6.2.1 Europe Bioidentical Hormones Sales in Volume by Country (2024-2029)
6.2.2 Europe Bioidentical Hormones Sales in Value by Country (2024-2029)
7 Asia-Pacific Bioidentical Hormones by Region
7.1 Asia-Pacific Bioidentical Hormones Historic Market Size by Region
7.1.1 Asia-Pacific Bioidentical Hormones Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Bioidentical Hormones Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Bioidentical Hormones Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Bioidentical Hormones Forecasted Market Size by Region
7.2.1 Asia-Pacific Bioidentical Hormones Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Bioidentical Hormones Sales in Value by Region (2024-2029)
8 Latin America Bioidentical Hormones by Country
8.1 Latin America Bioidentical Hormones Historic Market Size by Country
8.1.1 Latin America Bioidentical Hormones Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Bioidentical Hormones Sales in Volume by Country (2018-2023)
8.1.3 Latin America Bioidentical Hormones Sales in Value by Country (2018-2023)
8.2 Latin America Bioidentical Hormones Forecasted Market Size by Country
8.2.1 Latin America Bioidentical Hormones Sales in Volume by Country (2024-2029)
8.2.2 Latin America Bioidentical Hormones Sales in Value by Country (2024-2029)
9 Middle East and Africa Bioidentical Hormones by Country
9.1 Middle East and Africa Bioidentical Hormones Historic Market Size by Country
9.1.1 Middle East and Africa Bioidentical Hormones Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Bioidentical Hormones Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Bioidentical Hormones Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Bioidentical Hormones Forecasted Market Size by Country
9.2.1 Middle East and Africa Bioidentical Hormones Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Bioidentical Hormones Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 SottoPelle
10.1.1 SottoPelle Company Information
10.1.2 SottoPelle Introduction and Business Overview
10.1.3 SottoPelle Bioidentical Hormones Sales, Revenue and Gross Margin (2018-2023)
10.1.4 SottoPelle Bioidentical Hormones Products Offered
10.1.5 SottoPelle Recent Development
10.2 BioTE Medical
10.2.1 BioTE Medical Company Information
10.2.2 BioTE Medical Introduction and Business Overview
10.2.3 BioTE Medical Bioidentical Hormones Sales, Revenue and Gross Margin (2018-2023)
10.2.4 BioTE Medical Bioidentical Hormones Products Offered
10.2.5 BioTE Medical Recent Development
10.3 Advantage Pharmaceuticals
10.3.1 Advantage Pharmaceuticals Company Information
10.3.2 Advantage Pharmaceuticals Introduction and Business Overview
10.3.3 Advantage Pharmaceuticals Bioidentical Hormones Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Advantage Pharmaceuticals Bioidentical Hormones Products Offered
10.3.5 Advantage Pharmaceuticals Recent Development
10.4 Full Life Wellness Center
10.4.1 Full Life Wellness Center Company Information
10.4.2 Full Life Wellness Center Introduction and Business Overview
10.4.3 Full Life Wellness Center Bioidentical Hormones Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Full Life Wellness Center Bioidentical Hormones Products Offered
10.4.5 Full Life Wellness Center Recent Development
10.5 Neuva Aesthetics
10.5.1 Neuva Aesthetics Company Information
10.5.2 Neuva Aesthetics Introduction and Business Overview
10.5.3 Neuva Aesthetics Bioidentical Hormones Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Neuva Aesthetics Bioidentical Hormones Products Offered
10.5.5 Neuva Aesthetics Recent Development
10.6 Defy Medical
10.6.1 Defy Medical Company Information
10.6.2 Defy Medical Introduction and Business Overview
10.6.3 Defy Medical Bioidentical Hormones Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Defy Medical Bioidentical Hormones Products Offered
10.6.5 Defy Medical Recent Development
10.7 Biostation
10.7.1 Biostation Company Information
10.7.2 Biostation Introduction and Business Overview
10.7.3 Biostation Bioidentical Hormones Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Biostation Bioidentical Hormones Products Offered
10.7.5 Biostation Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Bioidentical Hormones Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Bioidentical Hormones Industrial Chain Analysis
11.4 Bioidentical Hormones Market Dynamics
11.4.1 Bioidentical Hormones Industry Trends
11.4.2 Bioidentical Hormones Market Drivers
11.4.3 Bioidentical Hormones Market Challenges
11.4.4 Bioidentical Hormones Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Bioidentical Hormones Distributors
12.3 Bioidentical Hormones Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
